Mimedx (MDXG) Gross Profit (2011 - 2026)

Mimedx (MDXG) has 16 years of Gross Profit data on file, last reported at $41.6 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 41.91% year-over-year to $41.6 million; the trailing twelve-month figure through Mar 2026 stood at $315.6 million (up 9.3% YoY), and the FY2025 full-year result was $345.6 million, up 19.67% from the prior year.
• Gross Profit retreated to $41.6 million in Q1 2026, from $99.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $99.0 million in Q4 2025 to a low of $41.6 million in Q1 2026.
• A 5-year average of $68.4 million and a median of $68.7 million in 2024 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit soared 38.22% in 2025 and tumbled 41.91% in 2026, its largest moves.
• Tracing MDXG's Gross Profit over 5 years: stood at $60.0 million in 2022, then rose by 21.64% to $73.0 million in 2023, then gained by 4.12% to $76.0 million in 2024, then surged by 30.32% to $99.0 million in 2025, then sank by 57.97% to $41.6 million in 2026.
• Business Quant data shows MDXG's Gross Profit at $41.6 million in Q1 2026, $99.0 million in Q4 2025, and $95.0 million in Q3 2025.